公开(公告)号：US20240325356A1

公开(公告)日：2024-10-03

申请号：US18741528

申请日：2024-06-12

Applicant: Kowa Company, Ltd

Inventor： Yusuke Sasaki ,  Masato Asahiyama ,  Toshiya Tanaka

IPC: A61K31/423 ,  A61K31/7034 ,  A61K31/7048 ,  A61P1/16

CPC classification number: A61K31/423 ,  A61P1/16 ,  A61K31/7034 ,  A61K31/7048

Abstract: The present invention addresses the problem of providing a medicinal composition and a drug combination by which nonalcoholic fatty liver disease and nonalcoholic steatohepatitis can be prevented and/or treated. The present invention provides a combination of a peroxisome proliferator-activated receptor (PPAR) a agonist with a sodium glucose cotransporter 2 (SGLT2) inhibitor, which is to be used for preventing and/or treating nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

公开(公告)号：USD1022002S1

公开(公告)日：2024-04-09

申请号：US29835756

申请日：2022-04-21

Applicant: KOWA COMPANY, LTD.

Designer： Kentaro Kaneko

Abstract: FIG. 1 is a front perspective view of an industrial camera showing my new design;
FIG. 2 is a rear perspective view thereof;
FIG. 3 is a front view thereof;
FIG. 4 is a rear view thereof;
FIG. 5 is a left side elevational view thereof;
FIG. 6 is a right side elevational view thereof;
FIG. 7 is a top plan view thereof; and,
FIG. 8 is a bottom plan view thereof.
The broken lines depict portions of the industrial camera in which the design is embodied that form no part of the claimed design.

公开(公告)号：US20230414578A1

公开(公告)日：2023-12-28

申请号：US18244628

申请日：2023-09-11

Applicant: KOWA COMPANY, LTD.

Inventor： Akito MINAMIZONO

IPC: A61K31/423 ,  A61K9/28

CPC classification number: A61K31/423 ,  A61K9/2813 ,  A61K9/282

Abstract: Provided is a pharmaceutical composition which contains pemafibrate, a salt thereof or a solvate thereof and one or more selected from the group consisting of a metal oxide, a dihydric alcohol, an ester species and a silicic acid compound and which has excellent storage stability. The pharmaceutical composition includes the following components (A) and (B): (A) pemafibrate, a salt thereof or a solvate thereof; and (B) one or more selected from the group consisting of the following components (B-1) to (B-4): (B-1) a metal oxide; (B-2) a dihydric alcohol; (B-3) an ester species; and (B-4) a silicic acid compound, with component (A) and component (B) being substantially in non-contact with each other.

公开(公告)号：US20230338365A1

公开(公告)日：2023-10-26

申请号：US17998308

申请日：2021-05-14

Applicant: KOWA COMPANY, LTD.

Inventor： Mutsuo OKUMURA ,  Seiichi MURAKAMI

IPC: A61K31/4748 ,  A61K9/00

CPC classification number: A61K31/4748 ,  A61K9/0073

Abstract: Provided is a novel inhalant as a therapeutic agent for COVID-19. The present invention relates to an inhalant containing cepharanthine.

公开(公告)号：US20230301775A1

公开(公告)日：2023-09-28

申请号：US18023704

申请日：2021-10-07

Applicant: KOWA COMPANY, LTD.

Inventor： Shuji ABE ,  Yasuhiro HISHINUMA ,  Kotaro MITSUMOTO ,  Haruo ISHIKAWA ,  Norio SHIMIZU

IPC: A61F2/16

CPC classification number: A61F2/1618 ,  A61F2/1654 ,  G02B27/4205

Abstract: A multifocal diffractive lens is provided which achieves efficient use of light. The multifocal diffractive lens 100 includes a diffraction grating 1c. Negative-order light L2 produces a focal point f2 for far vision and 0-order light L1 produces a focal point f1 nearer to that for far vision. The number of focal points is two or more. The focal position fc for far vision in polychromatic performance evaluation is located nearer to the multifocal diffractive lens than the focal position fs for far vision in monochromatic performance evaluation.

公开(公告)号：US11730719B2

公开(公告)日：2023-08-22

申请号：US17591108

申请日：2022-02-02

Applicant: KOWA COMPANY, LTD.

Inventor： Shin Sugimoto ,  Akito Minamizono

IPC: A61K31/423

CPC classification number: A61K31/423

Abstract: Provided is a pharmaceutical composition which contains pemafibrate, a salt thereof or a solvate thereof and has excellent stability. A pharmaceutical composition is provided containing pemafibrate, a salt thereof or a solvate thereof and having a moisture content of 2.4 mass % or less.

公开(公告)号：US20220265170A1

公开(公告)日：2022-08-25

申请号：US17596804

申请日：2020-06-24

Applicant: KOWA COMPANY, LTD.

Inventor： Katsumi YABUSAKI ,  Nakahiro KATO ,  Miyako SUZUKI

IPC: A61B5/1455 ,  A61B5/00 ,  A61B5/145

Abstract: An object of the present invention is to provide a technique that can improve the measurement accuracy of the blood component concentration. A blood component measurement system emits light to a measurement site of a living body while the measurement site is compressed, and calculates a concentration of a predetermined blood component based on a pulse wave signal acquired based on light received from the measurement site. A blood component measurement system includes a processing unit that performs a process of analyzing the pulse wave signal and determining a pressure condition of the measurement site; and a calculation unit that calculates a concentration of the blood component using the pulse wave signal in a period in which the pressure condition is determined.

公开(公告)号：US11419854B2

公开(公告)日：2022-08-23

申请号：US16609249

申请日：2018-06-29

Applicant: KOWA COMPANY, LTD.

Inventor： Satoshi Kojima ,  Ryohei Tanigawa

IPC: A61K31/423 ,  A61P1/16 ,  A61P3/06 ,  A61P3/10 ,  A61P9/00 ,  A61P9/10 ,  A61P43/00

Abstract: To provide an appropriate method of treatment with pemafibrate for a liver cirrhosis patient.
The present invention relates to the use of pemafibrate in a liver cirrhosis patient.
More particularly, the present invention relates to a regimen for administering a reduced dose of pemafibrate to a liver cirrhosis patient in need of treatment with pemafibrate than to persons with normal liver function.

公开(公告)号：US11406621B2

公开(公告)日：2022-08-09

申请号：US16627141

申请日：2018-06-29

Applicant: KOWA COMPANY, LTD.

Inventor： Shin Sugimoto ,  Akito Minamizono

IPC: A61K31/423 ,  A61K47/26 ,  A61K47/38

Abstract: Provided is a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and having excellent homogeneity. The pharmaceutical composition is provided containing the following components (A) and (B): (A) pemafibrate, a salt thereof or a solvate thereof; and (B) a disaccharide species.

公开(公告)号：US20220232155A1

公开(公告)日：2022-07-21

申请号：US17615085

申请日：2020-05-29

Applicant: Kowa Company, Ltd.

Inventor： Yutaka MIZUKUSA ,  Kunitoshi SHIMIZU

IPC: H04N5/235 ,  H04N5/225

Abstract: In order to obtain an inspection image without blown-out highlights generated due to specular reflection or the like or blocked-up shadows generated at a position to which light hardly reaches, an image processing device includes a plurality of light sources that irradiates an object with light and a control circuit that controls light emission of the plurality of light sources, a camera that photographs the object, and a processor that controls switching of a light emission pattern of the plurality of light sources and controls photographing execution timing of the camera, controls the plurality of light sources to emit light with a plurality of light emission patterns, performs photographing at timings during at least two or more patterns among the plurality of light emission patterns to obtain a plurality of intermediate images, and generates one final image based on the plurality of obtained intermediate images.